These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 722712)

  • 21. Synthesis of biologically active canine CCK-58.
    Reeve JR; Keire DA; Coskun T; Green GM; Evans C; Ho FJ; Lee TD; Davis MT; Shively JE; Solomon TE
    Regul Pept; 2003 May; 113(1-3):71-7. PubMed ID: 12686463
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Calcitonin gene-related peptide as modulator of cholecystokinin-induced contraction of guinea pig gall bladder strips in vitro.
    Kline LW; Pang PK
    Ann N Y Acad Sci; 1992 Jun; 657():541-2. PubMed ID: 1637119
    [No Abstract]   [Full Text] [Related]  

  • 23. 2-Phenylethyl ester and 2-phenylethyl amide derivative analogues of the C-terminal hepta- and octapeptide of cholecystokinin.
    Fulcrand P; Rodriguez M; Galas MC; Lignon MF; Laur J; Aumelas A; Martinez J
    Int J Pept Protein Res; 1988 Nov; 32(5):384-95. PubMed ID: 2463231
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In-vitro bioassays for cholecystokinin.
    Sjödin L; Nederman T; Olsson PA; Viitanen E
    J Pharm Pharmacol; 1989 Jun; 41(6):402-6. PubMed ID: 2476543
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interaction of gastrin I, secretin, and cholecystokinin on gallbladder smooth muscle.
    Ryan J; Cohen S
    Am J Physiol; 1976 Mar; 230(3):553-6. PubMed ID: 1266957
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Responses of guinea-pig gastric, ileal and gall bladder smooth muscle to desamino-cholecystokinin-octapeptide (CCK 7).
    Nieber K; Milenov K; Rakovska A; Henklein P; Oehme P
    Methods Find Exp Clin Pharmacol; 1988 Aug; 10(8):513-20. PubMed ID: 2852288
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Synthesis and biological activity of new cholecystokinin (CCK)-analogs with a special CCK-A receptor antagonistic effect].
    Boomgaarden M; Henklein P; Sohr R; Morgenstern R; Martinez J; Ott T
    Pharmazie; 1990 May; 45(5):377-8. PubMed ID: 2395905
    [No Abstract]   [Full Text] [Related]  

  • 28. Role of sulfate ester in influencing biologic activity of cholecystokinin-related peptides.
    Vinayek R; Jensen RT; Gardner JD
    Am J Physiol; 1987 Feb; 252(2 Pt 1):G178-81. PubMed ID: 2435164
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence for cholecystokinin receptor subtype in endocrine pancreas.
    Verspohl EJ; Hafner B; He X; Knittel JJ
    Peptides; 1994; 15(8):1353-60. PubMed ID: 7535422
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modifying effect of bradykinin on motor activity in the guinea-pig gall bladder.
    Stasiewicz J; Szalaj W; Gabryelewicz A
    Clin Exp Pharmacol Physiol; 1977; 4(6):561-4. PubMed ID: 589871
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cholecystokinin analogs with suppressed central activities.
    Maletínská L; Pírková J; Hlavácek J; Slaninová J
    Peptides; 1998; 19(2):301-8. PubMed ID: 9493862
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Double bond isosteres of the peptide bond: synthesis and biological activity of cholecystokinin (CCK) C-terminal hexapeptide analogs.
    Shue YK; Tufano MD; Carrera GM; Kopecka H; Kuyper SL; Holladay MW; Lin CW; Witte DG; Miller TR; Stashko M
    Bioorg Med Chem; 1993 Sep; 1(3):161-71. PubMed ID: 8081848
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chicken gastrin: a member of the gastrin/CCK family with novel structure-activity relationships.
    Dimaline R; Lee CM
    Am J Physiol; 1990 Nov; 259(5 Pt 1):G882-8. PubMed ID: 2240228
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structure-activity relationships of gastrointestinal hormones: motilin, GIP, and [27-TYR]CCK-PZ.
    Yajima H; Kai Y; Ogawa H; Kubota M; Mori Y
    Gastroenterology; 1977 Apr; 72(4 Pt.2):793-6. PubMed ID: 190081
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and biological activity of 2-phenylethyl ester analogues of C-terminal heptapeptide of cholecystokinin modified in Trp 30 region.
    Rolland M; Rodriguez M; Lignon MF; Galas MC; Laur J; Aumelas A; Martinez J
    Int J Pept Protein Res; 1991 Aug; 38(2):181-92. PubMed ID: 1723720
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects on exocrine and endocrine rat pancreas of long-term administration of CCK-PZ (cholecystokinin-pancreozymin) or synthetic octapeptide - CCK-PZ.
    Arnesjö II; Lundquist I
    Scand J Gastroenterol; 1976; 11(5):529-35. PubMed ID: 785590
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The importance of the amino acid in position 32 of cholecystokinin in determining its interaction with cholecystokinin receptors on pancreatic acini.
    Pan GZ; Martinez J; Bodanszky M; Jensen RT; Gardner JD
    Biochim Biophys Acta; 1981 Dec; 678(3):352-7. PubMed ID: 6172156
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structure-activity relationship studies on cholecystokinin: analogues with partial agonist activity.
    Galas MC; Lignon MF; Rodriguez M; Mendre C; Fulcrand P; Laur J; Martinez J
    Am J Physiol; 1988 Feb; 254(2 Pt 1):G176-82. PubMed ID: 2450468
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Galanin: structure-dependent effect on pancreatic amylase secretion and jejunal strip contraction.
    Rossowski WJ; Zacharia S; Jiang NY; Mungan Z; Mills M; Ertan A; Coy DH
    Eur J Pharmacol; 1993 Aug; 240(2-3):259-67. PubMed ID: 7694859
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and biological evaluation of cholecystokinin analogs in which the Asp-Phe-NH2 moiety has been replaced by a 3-amino-7-phenylheptanoic acid or a 3-amino-6-(phenyloxy)hexanoic acid.
    Amblard M; Rodriguez M; Lignon MF; Galas MC; Bernad N; Artis-Noël AM; Hauad L; Laur J; Califano JC; Aumelas A
    J Med Chem; 1993 Oct; 36(20):3021-8. PubMed ID: 7692048
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.